Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring
Go back to Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring| (NASDAQ: COYA) | Delayed: 5.75 -0.01 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.76 | 52 Week High | $ | |||
| Open | $5.72 | 52 Week Low | $ | |||
| Day High | $5.88 | P/E | N/A | |||
| Day Low | $5.42 | EPS | $ | |||
| Volume | 305,932 | |||||
